As of Dec 01
| +0.40 / +1.27%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 35.50, with a high estimate of 45.00 and a low estimate of 16.00. The median estimate represents a +11.29% increase from the last price of 31.90.
The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.